Tekla Competitors
| HQH Stock | USD 19.09 0.32 1.65% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Tekla Healthcare competition on your existing holdings.
As of now, Tekla Healthcare's Return On Tangible Assets are increasing as compared to previous years. The Tekla Healthcare's current Return On Assets is estimated to increase to 0.21, while Return On Capital Employed is forecasted to increase to (0.0002). As of now, Tekla Healthcare's Asset Turnover is decreasing as compared to previous years. Tekla Healthcare Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tekla Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Tekla and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tekla Healthcare Inv does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tekla Stock performing well and Tekla Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tekla Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NMFC | 0.96 | (0.03) | (0.02) | 0.05 | 1.17 | 2.67 | 7.02 | |||
| KBDC | 0.95 | 0.08 | 0.06 | 0.17 | 1.05 | 2.84 | 5.74 | |||
| VRTS | 1.49 | (0.23) | 0.00 | (0.12) | 0.00 | 2.94 | 8.92 | |||
| TRIN | 0.96 | 0.07 | 0.03 | 0.18 | 1.35 | 2.43 | 7.77 | |||
| PFLT | 0.90 | 0.10 | 0.08 | 0.19 | 0.94 | 2.40 | 6.09 | |||
| HRZN | 1.18 | 0.12 | 0.07 | 0.24 | 1.13 | 2.71 | 11.63 | |||
| CGBD | 1.07 | 0.03 | 0.01 | 0.10 | 1.34 | 2.30 | 7.06 | |||
| PX | 1.67 | (0.18) | 0.00 | (0.02) | 0.00 | 2.65 | 9.58 | |||
| MFIC | 0.93 | (0.05) | (0.04) | 0.01 | 1.42 | 2.01 | 6.99 | |||
| BCSF | 1.00 | 0.01 | 0.00 | 0.08 | 1.28 | 2.69 | 6.59 |
Cross Equities Net Income Analysis
Compare Tekla Healthcare Inv and related stocks such as New Mountain Finance, Kayne Anderson BDC, and Virtus Investment Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NMFC | (1.2 M) | 31.7 M | 31.8 M | 61.9 M | 45.6 M | 33 M | 111.7 M | 109.4 M | 72.4 M | 112.6 M | 58.5 M | 201.4 M | 74.7 M | 135.3 M | 113.4 M | 130.5 M | 89.4 M |
| KBDC | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 45.8 M | 77.1 M | 131.9 M | 151.7 M | 76.2 M |
| VRTS | 15.7 M | 145.4 M | 37.7 M | 75.2 M | 97.7 M | 35.1 M | 48.5 M | 37 M | 75.5 M | 95.6 M | 80 M | 208.1 M | 117.5 M | 130.6 M | 121.7 M | 140 M | 147 M |
| TRIN | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (524 K) | (6.1 M) | 132.3 M | (30.4 M) | 76.9 M | 115.6 M | 132.9 M | 139.6 M |
| PFLT | 12 M | 12 M | 12 M | 20.5 M | 12.5 M | 33.5 M | 36.3 M | 33.5 M | (11.1 M) | 18.4 M | 56.5 M | 3.5 M | 39.3 M | 91.8 M | 66.4 M | 76.3 M | 80.1 M |
| HRZN | 9.3 M | 11 M | 4 M | 3.5 M | 15.4 M | 11.9 M | (4.9 M) | 9.6 M | 13 M | 19.5 M | 6.4 M | 27.8 M | 21.2 M | (17.2 M) | (5.6 M) | (5.1 M) | (4.8 M) |
| CGBD | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | 5.6 M | 18.7 M | 69.8 M | 84.2 M | 39.1 M | 61.3 M | 6.8 M | 160.4 M | 85.6 M | 92.3 M | 89 M | 102.3 M | 65.2 M |
| PX | 585 M | 1.7 B | (1.9 M) | (8.4 M) | (12.8 M) | (6.5 M) | (15.9 M) | (1.4 M) | (2.9 M) | 11.9 M | 23.8 M | 10.8 M | 29.2 M | (7.1 M) | 18.7 M | 16.8 M | 16 M |
| MFIC | 44.1 M | (86.3 M) | 104.5 M | 270.9 M | 75.4 M | (44.5 M) | 18.4 M | 87 M | 71.9 M | (116.1 M) | 111.9 M | 82.4 M | 30.6 M | 118.8 M | 98.8 M | 113.6 M | 57.6 M |
| BCSF | 609 K | 609 K | 609 K | 609 K | 609 K | 609 K | 609 K | 19.3 M | 26.6 M | 98.1 M | 8.3 M | 119.8 M | 105.5 M | 123.4 M | 119.4 M | 137.3 M | 75.9 M |
Tekla Healthcare Inv and related stocks such as New Mountain Finance, Kayne Anderson BDC, and Virtus Investment Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Tekla Healthcare Inv financial statement analysis. It represents the amount of money remaining after all of Tekla Healthcare Investors operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Tekla Healthcare Competitive Analysis
The better you understand Tekla Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tekla Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tekla Healthcare's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Tekla Healthcare Competition Performance Charts
Five steps to successful analysis of Tekla Healthcare Competition
Tekla Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tekla Healthcare Inv in relation to its competition. Tekla Healthcare's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Tekla Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tekla Healthcare's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tekla Healthcare Inv, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Tekla Healthcare position
In addition to having Tekla Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Absolute Returns ETFs Thematic Idea Now
Absolute Returns ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Absolute Returns ETFs theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Absolute Returns ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Tekla Healthcare Correlation with its peers. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.911 | Dividend Share 2.24 | Earnings Share 1.61 | Revenue Per Share | Quarterly Revenue Growth (0.49) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.